Supernus Pharmaceuticals (SUPN) News
NASDAQ: SUPNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
42.67+0.53 (+1.26%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
SUPN news summary
We found 1 recent headline mentioning Supernus Pharmaceuticals (SUPN): 0 in the past week and 0 in the past 30 days, most often from Nasdaq. For price context, SUPN is up 1.26% at $42.67. The most recent story, "Stocks Rally on Easing Geopolitical Risks and US Economic Strength", was published by Nasdaq on Aug 3, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology